DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /MorpholinesMorpholines
  6. /SGC-CBP30SGC-CBP30
Chemical structure of CAS 1613695-14-9

SGC-CBP30

CAS No.1613695-14-9
MDL No.MFCD26792586
MFC28H33ClN4O3
MW509.00
InChI KeyGEPYBHCJBORHCE-SFHVURJKSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1613695-14-9
Product NameSGC-CBP30
HCode:H413
PCode:P273-P501

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines.

Molecular cancer research : MCR • Vol. 17, Issue 3 • 2019
PMID: 30606771DOI: 10.1158/1541-7786.MCR-18-0719

SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes.

The Journal of clinical investigation • Vol. 128, Issue 9 • 2018
PMID: 30059018PMC: PMC6118635DOI: 10.1172/JCI98786

Activity of bromodomain protein inhibitors/binders against asexual-stage Plasmodium falciparum parasites.

International journal for parasitology. Drugs and drug resistance • Vol. 8, Issue 2 • 2018
PMID: 29631126PMC: PMC6039313DOI: 10.1016/j.ijpddr.2018.03.001

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact